FDA Inspection 1067227 — Midwest Transplant Network
The FDA completed an inspection of Midwest Transplant Network on Sep 13, 2018 in Westwood, KS. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 13, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Westwood, KS (United States)